Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neurotech Pharmaceuticals
With
The Lowy Medical Research Institute Limited
The Emmes Company, LLC
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant must be offered sufficient opportunity to review and to understand the informed consent form, agree to the form's contents and sign the protocol's informed consent
Participant must have at least one study eye with a positive diagnosis of MacTel Type 2
Participant must have an IS/OS PR break in the study eye(s) and en face ellipsoid zone (area of IS/OS loss) as measured by SDOCT between 0.16 mm2 and 4.00 mm2
If female, participant must be incapable of pregnancy
If male, participant must agree to use an effective form of birth control during the study
You may not be if
Participant is unable to provide informed consent
Participant is less than 21 years of age or greater than 80 years of age
Participant is medically unable to comply with study procedures or follow-up visits
Participant was a study subject in any other clinical trial of an intervention (drug or device) within the last 6 months
Participant is pregnant or breastfeeding
Clareo Health | A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel
